57 results on '"Lau, Daryl T Y"'
Search Results
2. A Rare Case of Recurrent Intrahepatic Cholestasis of Pregnancy With Prolonged Postpartum Hepatic Inflammation Despite Normalization of Bile Acid Levels
3. Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update
4. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook
5. Case of cryoglobulinaemia associated with chronic hepatitis B
6. Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg)
7. Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure
8. Incidence and prediction of HBsAg seroclearance in a prospective multi‐ethnic HBeAg ‐negative chronic hepatitis B cohort
9. The dilemma of cytomegalovirus and hepatitis B virus interaction
10. Reply
11. Novel Therapies of Hepatitis B and D
12. Liver Cancer–Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma
13. A challenging case of alpha-fetoprotein-result discrepancies in a patient with chronic hepatitis B
14. Enhancing the nanoplasmonic signal by a nanoparticle sandwiching strategy to detect viruses
15. Improved hepatitis A and hepatitis B vaccination strategy is necessary for patients with chronic hepatitis C
16. Patterns of HBeAg and HBsAg clearance among a treatment‐naive Alaskan Cohort in a long‐term observational study
17. 16 Hepatitis C virus and human immunodeficiency virus coinfection
18. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection
19. An update on the management of chronic hepatitis D
20. A global scientific strategy to cure hepatitis B
21. Hepatic IFN-Induced Protein with Tetratricopeptide Repeats Regulation of HCV Infection
22. Correction: Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma
23. Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma
24. Management of chronic hepatitis B during pregnancy
25. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update
26. Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE 2 RD) for diagnostics
27. Recent advances in micro/nanotechnologies for global control of hepatitis B infection
28. Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype
29. IL-1β Production through the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver Inflammation and Disease
30. Innate Immune Tolerance and the Role of Kupffer Cells in Differential Responses to Interferon Therapy Among Patients With HCV Genotype 1 Infection
31. IFITM1 is a tight junction protein that inhibits hepatitis C virus entry
32. The need for clarity in occult HBV infection
33. Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony
34. Review: Current status of antiviral therapy for hepatitis B
35. Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients
36. A Pilot Study of Extended Duration Peginterferon Alfa-2a for Patients With Hepatitis B e Antigen-Negative Chronic Hepatitis B
37. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C
38. Hepatitis B: The Pathway to Recovery Through Treatment
39. Hepatitis B: The Pathway to Recovery Through Treatment
40. APRI: An Easy and Validated Predictor of Hepatic Fibrosis in Chronic Hepatitis C
41. Hepatitis B: The Pathway to Recovery Through Treatment
42. A Framework for Management of Hepatitis C in Prisons
43. Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection
44. Screening for hepatitis A and B antibodies in patients with chronic liver disease
45. Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis
46. Differences in long‐term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed
47. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed
48. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector
49. THE APRI IS A GOOD PREDICTOR OF FIBROSIS IN HCV, AND MAY BE ENHANCED BY THE INSULIN RESISTANCE INDEX (HOMA-IR). A PROSPECTIVE STUDY
50. Antiviral therapy for treatment-naı̈ve hepatitis B virus patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.